Elon Musk shares his remarkable transformation after using diabetes medication, revealing how it has positively impacted his health.
Elon Musk, the CEO of Tesla and SpaceX, has recently shared his impressive weight loss journey with the public.
This Christmas, he showcased his new physique on social media, revealing that he achieved this transformation with the help of diabetes medication.
Musk specifically mentioned using a drug called Mounjaro, which is becoming popular for weight loss.
Tesla CEO announced his weight loss journey on social media.
Musk announced his social media platform, X (formerly Twitter), where he posted a festive photo of himself dressed as Santa Claus.
He humorously captioned the image, “Ozempic Santa — Like Cocaine Bear, but Santa and Ozempic!”
Although he initially referred to Ozempic, he quickly clarified that he is using Mounjaro, another drug in the same class.
Mounjaro and Ozempic are both GLP-1 inhibitors.
These medications were originally developed to help people with diabetes manage their blood sugar levels.
However, they have gained attention for their effectiveness in aiding weight loss.
Musk’s choice of Mounjaro over Ozempic is based on his experience.
He noted that he prefers Mounjaro because it seems to have fewer side effects.
Elon Musk shared his side effects from Ozempic humorously
In his post, Musk joked about the side effects he experienced while using Ozempic.
“High doses of [Ozempic] made me fart & burp like Barney from the Simpson’s,” Musk joked, adding: “Mounjaro seems to have fewer side effects and be more effective.”
His lighthearted comment highlighted the challenges some users face when taking these medications.
By contrast, he feels that Mounjaro works better for him with fewer unpleasant effects.
Musk’s transformation has sparked discussions about the use of weight-loss drugs and their role in addressing obesity in America.
He has become a vocal advocate for GLP-1 inhibitors, believing they can be a part of the solution to the country’s ongoing obesity crisis.
Elon Musk and Kennedy clash over obesity treatment methods.
Musk’s views on weight loss medications have not gone unchallenged. Robert F. Kennedy Jr., who will be the new Health and Human Services Secretary, disagrees with Musk.
Kennedy supports focusing on healthier eating and lifestyle changes rather than relying on medications.
He argues that improving diet can be a more sustainable and cost-effective way to combat obesity.
This difference in opinion may lead to debates as both prepare for leadership roles in Trump’s administration.
Musk is set to lead a new department aimed at improving governmental efficiency, while Kennedy will focus on health issues.
Elon Musk’s method receives support from celebrities
Musk’s endorsement of Mounjaro has received support from unexpected places.
Whoopi Goldberg, a well-known actress and TV host, has spoken openly about her own experience with the medication.
She agrees with Musk’s stance on using GLP-1 inhibitors like Mounjaro for weight loss.
During a recent episode of “The View,” she shared her personal weight-loss journey, revealing that she once weighed nearly 300 pounds.
“I’m doing that wonderful shot that works for folks who need some help and it’s been really good for me,” she revealed on The Kelly Clarkson Show.
Goldberg expressed her belief in the effectiveness of Mounjaro, stating, “Elon’s right on this!”
Her comments contribute to the growing debate on the benefits and challenges of weight management medications.